ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

July 22, 2011

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011